For the first time, preliminary 1-year data from 3 patients implanted with Xeltis’ restorative pulmonary #heartvalve will be presented at ECHSA by Prof. Tomasz Mroczek’s on June 1. xeltis.com/news #ECHSA2018 #1in100 #RVOT #CHDaware

Delighted to be included in Silicon Republic's '12 innovative European medtech start-ups to watch'; learn more about how we are naturally restoring the heart valve here: Xeltis.com/technology x.com/siliconrepubli…

Great news from Dynacure today on the path to ASO clinical trials for centronuclear myopathy. We are delighted to have been part of the journey to fund research into DNM2 down regulation. With thanks as ever to all of our great supporters who make such research possible x.com/dynacure/statu…

We’re pleased to let you know that UCL Queen Square Institute of Neurology is recruiting people with Inclusion Body Myositis (IBM) to take part in the @Orphazyme_AS clinical trial. Find out how you can take part here: qoo.ly/rp58v

Kurma Partners Announces First Closing of Kurma Biofund III; Targets €150m servier.com/en/communique/… KurmaPartners Servier More French life science business news at [LSE] at Life-Sciences-Europe.com/news/life-scie…

Spreading good Kurma: How KurmaPartners is expanding its preseed partnership approach beyond France, rare diseases with its €150 Biofund III buff.ly/2Bi6hzF

We are happy to announce the launch of our Munich operations headed by newlyappointed Partner Peter Neubeck. Read the PR here …rtners-website-backend.cdn.prismic.io/kurma-partners… #venturecapital #earlystage #biotechnology #germany

🚀Erganeo helps launch start-up Ermium Therapeutics, which has already raised €6.3m in #startup capital : erganeo.com/en/Ermium_rais… #health #diseases #immunomodulators @DOMAINTherapeut KurmaPartners Eurazeo Investment Manager A project CNRS Innovation @UParisDescartes Erganeo Réseau SATT

Many thanks to all #entrepreneurs at the Eurazeo Investment Manager x KurmaPartners #health #startup dinner on Idinvest's terrace last night!

HTGF: Tacalyx Raises €7m in Seed Funding to Generate First in Class Anti-TACA Antibodies for Cancer Treatment high-tech-gruenderfonds.de/en/tacalyx-rai… HTGF Boehringer Ingelheim KurmaPartners Creathor Ventures #Tacalyx More German life science business news at [LSG] at life-sciences-germany.com/news/Life-Scie…

.KurmaPartners' new Munich office bears 1st fruit, Max Planck spinout Tacalyx, helmed by Shire, Baxalta vet Peter Sondermann BioCentury's @iBonanos reports: biocentury.com/biocentury/fin…

🌐 #SaclayCrunch Venez écouter #startups sélectionnées par Partech Shaker & KurmaPartners le 08/10 aux côtés des 7 grands groupes partenaires Orange BNP Paribas Group Groupama JCDecaux France Cisco Econocom CHANEL 👉 bit.ly/2LJ0ABe CentraleSupélec École polytechnique

Say hello to this year's #BIOEurope #StartupSlam judges 👋 @GA_Tech TVM Capital Life Science Johnson & Johnson Innovation KurmaPartners Holger Reithinger Moderated by: Joachim Eeckhout of Labiotech.eu and @MadelaineH0lden See the full program now >> spr.ly/60171Jy1D Innovation Forum

Xeltis has been selected as one of three finalists for the Swiss Medtech Awards. Stay tuned on June 12 to find out the winner; xeltis.com/news #swissmedtechawards #swissmedtechday #innovation

#PitchContest Innovation 5 themes and a jury buff.ly/2pSdx0g Amine M KurmaPartners Theme : Health #ParisSaclaySpring #SaveTheDate #SmartWeeks #VivaTech #TakeMeToParisSaclay #Innovation Région Île-de-France Startup.info "

“We are proud to be among the last finalists for this high-profile award. This accolade recognizes the potential of our restorative device to make a difference in the lives of children born with congenital heart disease,” said Xeltis CEO @lgrandidier_ xeltis.com/news/

Xeltis’ restorative heart valves will be in the spotlight at @ICTEHV in Amsterdam on May 18. Professor FJ Schoen, @HarvardMed and CTO Martijn Cox will provide insights on the technology and on preclinical data. xeltis.com/news #RVOT #ICTEHV #innovation #medtech